Randomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering Therapy
Table 5
Liver Fat Content, Fasting Levels of Alanine Aminotransferase, and Percent Change in LDL-C in Patients with Post-Baseline For-Cause Magnetic Resonance Imaging Assessments.